Aflibercept (Eylea)
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Aflibercept (Eylea), covering 2017-03-27 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy of Aflibercept for the Treatment of Inflammatory CNV in Young Patients (ALINEA). [Phase 2]